“…With the recent rapid evolution of affordable next‐generation sequencing methods, there is increased recognition of HPS subjects and new HPS genetic subtypes (Arcot Sadagopan et al, 2017; Wei et al, 2016; Yousaf et al, 2016). This is also evidenced by the increased diagnosis of subjects with nonclassic HPS phenotypes (i.e., HPS‐2, HPS‐7, HPS‐8, HPS‐9, and HPS‐10; Ammann et al, 2016; Bryan et al, 2017; Cetica et al, 2015; Iwata et al, 2017; Okamura et al, 2018), as well as diagnosis of “unexpected” HPS in cohorts with albinism (S. Ito et al, 2005; Khan et al, 2016), immunodeficiency (Badolato et al, 2012), ocular disease (Hull et al, 2016; Miyamichi et al, 2016), or platelet disorders (Jones et al, 2012).…”